Last Price
0.373
Today's Change
-0.001 (0.26%)
Day's Change
0.358 - 0.385
Trading Volume
97,789
Exchange: NASDAQ Capital Market NASDAQ Capital Market
Currency: USD USD
Sector: Healthcare - Healthcare Healthcare - Healthcare
CEO: Dr. Meeshanthini V. Dogan Ph.D. Dr. Meeshanthini V. Dogan Ph.D.
Full Time Employees: 13 13
IPO Date: 2022-01-14 2022-01-14
CIK: 0001870144 0001870144
ISIN: US14159C1036 US14159C1036
CUSIP: 14159C103 14159C103
Beta: 3.68 3.68
Last Dividend: 0.00 0.00
Dcf Diff: 0.15 0.15
Dcf: 0.24 0.24
Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.